Skip to main content
Erschienen in: Journal of Hepato-Biliary-Pancreatic Sciences 1/2008

Open Access 01.01.2008

Diagnosis of biliary tract and ampullary carcinomas

verfasst von: Kazuhiro Tsukada, Tadahiro Takada, Masaru Miyazaki, Shuichi Miyakawa, Masato Nagino, Satoshi Kondo, Junji Furuse, Hiroya Saito, Toshio Tsuyuguchi, Fumio Kimura, Hideyuki Yoshitomi, Satoshi Nozawa, Masahiro Yoshida, Keita Wada, Hodaka Amano, Fumihiko Miura

Erschienen in: Journal of Hepato-Biliary-Pancreatic Sciences | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Diagnostic methods for biliary tract carcinoma and the efficacy of these methods are discussed. Neither definite methods for early diagnosis nor specific markers are available in this disease. When this disease is suspected on the basis of clinical symptoms and risk factors, hemato-biochemical examination and abdominal ultrasonography are performed and, where appropriate, enhanced computed tomography (CT) and/or magnetic resonance cholangiopancreatography (MRCP) is carried out. Diagnoses of extrahepatic bile duct cancer and ampullary carcinoma are often made based on the presence of obstructive jaundice. Although rare, abdominal pain and pyrexia, as well as abnormal findings of the hepatobiliary system detected by hemato-biochemical examination, serve as a clue to making a diagnosis of these diseases. On the other hand, the early diagnosis of gallbladder cancer is scarcely possible on the basis of clinical symptoms, so when this cancer is found with the onset of abdominal pain and jaundice, it is already advanced at the time of detection, thus making a cure difficult. When gallbladder cancer is suspected, enhanced CT is carried out. Multidetector computed tomography (MDCT), in particular — one of the methods of enhanced CT — is useful for decision of surgical criteria, because MDCT shows findings such as localization and extension of the tumor, and the presence or absence of remote metastasis. Procedures such as magnetic resonance imaging, endoscopic ultrasonography, bile duct biopsy, and cholangioscopy should be carried out taking into account indications for these procedures in individual patients. However, direct biliary tract imaging is necessary for making a precise diagnosis of the horizontal extension of bile duct cancer.
Literatur
1.
Zurück zum Zitat Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Kondo S, et al. Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 2008;15:2–6.CrossRefPubMed Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, Kondo S, et al. Purpose, use, and preparation of clinical practice guidelines for the management of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 2008;15:2–6.CrossRefPubMed
2.
Zurück zum Zitat Yeo CJ, Pitt HA, Cameron JL. Cholangiocarcinoma. Surg Clin N Am 1990;70:1429–47.PubMed Yeo CJ, Pitt HA, Cameron JL. Cholangiocarcinoma. Surg Clin N Am 1990;70:1429–47.PubMed
3.
Zurück zum Zitat Thuluvath PJ, Rai R, Venbrux AC, Yeo CJ. Cholangiocarcinoma: a review. Gastroenterologist 1997;5:306–15.PubMed Thuluvath PJ, Rai R, Venbrux AC, Yeo CJ. Cholangiocarcinoma: a review. Gastroenterologist 1997;5:306–15.PubMed
5.
Zurück zum Zitat Sugiyama M, Atomi Y, Kuroda A, Muto T. Bile duct carcinoma without jaundice: clues to early diagnosis. Hepatogastroenterology 1997;44:1477–83.PubMed Sugiyama M, Atomi Y, Kuroda A, Muto T. Bile duct carcinoma without jaundice: clues to early diagnosis. Hepatogastroenterology 1997;44:1477–83.PubMed
6.
Zurück zum Zitat Wanebo HJ, Castle WN, Fechner RE. Is carcinoma of the gallbladder a curable lesion? Ann Surg 1982;195:624–31.CrossRefPubMed Wanebo HJ, Castle WN, Fechner RE. Is carcinoma of the gallbladder a curable lesion? Ann Surg 1982;195:624–31.CrossRefPubMed
7.
Zurück zum Zitat Malik IA. Clinicopathological features and management of gallbladder cancer in Pakistan: a prospective study of 233 cases. J Gastroenterol Hepatol 2003;18:950–3.CrossRefPubMed Malik IA. Clinicopathological features and management of gallbladder cancer in Pakistan: a prospective study of 233 cases. J Gastroenterol Hepatol 2003;18:950–3.CrossRefPubMed
8.
Zurück zum Zitat Al-Quadah MS, Daradkeh S, Sroujieh AS, Farah GR, Masaad J. Gallbladder carcinoma in Jordan. Hepatogastroenterology 2005; 61:5–7. Al-Quadah MS, Daradkeh S, Sroujieh AS, Farah GR, Masaad J. Gallbladder carcinoma in Jordan. Hepatogastroenterology 2005; 61:5–7.
9.
Zurück zum Zitat Trede M. Periampullary and pancreatic cancer. In: Blumgart LH, editor. Surgery of the liver and biliary tract. 2nd ed. New York: Churchill Livingstone; 1994. p. 997–1008. Trede M. Periampullary and pancreatic cancer. In: Blumgart LH, editor. Surgery of the liver and biliary tract. 2nd ed. New York: Churchill Livingstone; 1994. p. 997–1008.
10.
Zurück zum Zitat Dijkum EJMN, Terwee CB, Oosterveld P, Meulen JHP, Gouma DJ, Haes JCJM. Validation of the gastrointestinal quality of life index for patients with potentially operable periampullary carcinoma. Br J Surg 2000;87:110–5.CrossRef Dijkum EJMN, Terwee CB, Oosterveld P, Meulen JHP, Gouma DJ, Haes JCJM. Validation of the gastrointestinal quality of life index for patients with potentially operable periampullary carcinoma. Br J Surg 2000;87:110–5.CrossRef
11.
Zurück zum Zitat Kamisawa T, Tu Y, Egawa N, Nakajima H, Horiguchi S, Tsuruta K, Okamoto A. Clinicopathologic features of ampullary carcinoma without jaundice. J Clin Gastroenterol 2006;40:162–6.CrossRefPubMed Kamisawa T, Tu Y, Egawa N, Nakajima H, Horiguchi S, Tsuruta K, Okamoto A. Clinicopathologic features of ampullary carcinoma without jaundice. J Clin Gastroenterol 2006;40:162–6.CrossRefPubMed
12.
Zurück zum Zitat de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. New Engl J Med 1999;341:1368–79.CrossRefPubMed de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. New Engl J Med 1999;341:1368–79.CrossRefPubMed
13.
Zurück zum Zitat Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005; 366:1303–14.CrossRefPubMed Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005; 366:1303–14.CrossRefPubMed
14.
Zurück zum Zitat Robledo R, Muro A, Prieto ML. Extrahepatic bile duct carcinoma. US characteristics and accuracy in demonstration of tumors. Radiology 1996;198:869–73.PubMed Robledo R, Muro A, Prieto ML. Extrahepatic bile duct carcinoma. US characteristics and accuracy in demonstration of tumors. Radiology 1996;198:869–73.PubMed
15.
Zurück zum Zitat Choi BL, Lee JH, Han MC, Kim SH, Yi JG, Kim CW. Hilar cholangiocarcinoma: Comparative study with sonography and CT. Radiology 1989;172:689–92.PubMed Choi BL, Lee JH, Han MC, Kim SH, Yi JG, Kim CW. Hilar cholangiocarcinoma: Comparative study with sonography and CT. Radiology 1989;172:689–92.PubMed
16.
Zurück zum Zitat Lillemoe KD. Tumors of the gallbladder, bile duct, and ampulla. Semin Gastrointest Dis 2003;14:208–21.PubMed Lillemoe KD. Tumors of the gallbladder, bile duct, and ampulla. Semin Gastrointest Dis 2003;14:208–21.PubMed
17.
Zurück zum Zitat Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003;4:167–76.CrossRefPubMed Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003;4:167–76.CrossRefPubMed
18.
Zurück zum Zitat Piantino P, Fusaro A, Randone A, Cerchier A, Daziano E. Increased levels of CA19-9, CA50 and CA125 in patients with benign disease of biliary tract and the pancreas. J Nucl Med Allied Sci 1990;34:97–102.PubMed Piantino P, Fusaro A, Randone A, Cerchier A, Daziano E. Increased levels of CA19-9, CA50 and CA125 in patients with benign disease of biliary tract and the pancreas. J Nucl Med Allied Sci 1990;34:97–102.PubMed
19.
Zurück zum Zitat Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000;95:204–7.CrossRefPubMed Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000;95:204–7.CrossRefPubMed
20.
Zurück zum Zitat Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, Ritts RE. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993;68:874–9.PubMed Nichols JC, Gores GJ, LaRusso NF, Wiesner RH, Nagorney DM, Ritts RE. Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. Mayo Clin Proc 1993;68:874–9.PubMed
21.
Zurück zum Zitat Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, et al.; British Society of Gastroenterology. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002;51:1–9.CrossRef Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, et al.; British Society of Gastroenterology. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002;51:1–9.CrossRef
22.
Zurück zum Zitat Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttilä I, Alhava E. Clinical value of serum tumor markers CEA, CA50 and CA242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis: results from a prospective study. Anticancer Res 1992;12:1687–93.PubMed Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttilä I, Alhava E. Clinical value of serum tumor markers CEA, CA50 and CA242 in the distinction between malignant versus benign diseases causing jaundice and cholestasis: results from a prospective study. Anticancer Res 1992;12:1687–93.PubMed
23.
Zurück zum Zitat Vij U, Baskaran V. Value of serum CEA and AFP in the diagnosis and prognosis of carcinoma gallbladder. Trop Gastroenterol 2001;22:227–9.PubMed Vij U, Baskaran V. Value of serum CEA and AFP in the diagnosis and prognosis of carcinoma gallbladder. Trop Gastroenterol 2001;22:227–9.PubMed
24.
Zurück zum Zitat Chaube A, Tewari M, Singh U, Shukla HS. CA 125: a potential tumor marker for gallbladder cancer. J Surg Oncol 2006;93:665–9.CrossRefPubMed Chaube A, Tewari M, Singh U, Shukla HS. CA 125: a potential tumor marker for gallbladder cancer. J Surg Oncol 2006;93:665–9.CrossRefPubMed
25.
Zurück zum Zitat Han JK, Choi BI, Kim AY, An SK, Lee JW, Kim TK, Kim SW. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics 2002;22:173–87.PubMed Han JK, Choi BI, Kim AY, An SK, Lee JW, Kim TK, Kim SW. Cholangiocarcinoma: pictorial essay of CT and cholangiographic findings. Radiographics 2002;22:173–87.PubMed
26.
Zurück zum Zitat Chen HW, Pan AZ, Zhen ZJ, Su SY, Wang JH, Yu SC, Lau WY. Preoperative evaluation of resectability of Klatskin tumor with 16-MDCT angiography and cholangiography. AJR Am J Roentgenol 2006;186:1580–6.CrossRefPubMed Chen HW, Pan AZ, Zhen ZJ, Su SY, Wang JH, Yu SC, Lau WY. Preoperative evaluation of resectability of Klatskin tumor with 16-MDCT angiography and cholangiography. AJR Am J Roentgenol 2006;186:1580–6.CrossRefPubMed
27.
Zurück zum Zitat Campbell WL, Peterson MS, Federle MP, Siqueira ES, Slivka A, Grazioli L, et al. Using CT and cholangiography to diagnose biliary tract carcinoma complicating primary sclerosing cholangitis. AJR Am J Roentgenol 2001;177:1095–100.PubMed Campbell WL, Peterson MS, Federle MP, Siqueira ES, Slivka A, Grazioli L, et al. Using CT and cholangiography to diagnose biliary tract carcinoma complicating primary sclerosing cholangitis. AJR Am J Roentgenol 2001;177:1095–100.PubMed
28.
Zurück zum Zitat Johnson KJ, Olliff JF, Olliff SP. The presence and significance of lymphadenopathy detected by CT in primary sclerosing cholangitis. Br J Radiol 1998;71:1279–82.PubMed Johnson KJ, Olliff JF, Olliff SP. The presence and significance of lymphadenopathy detected by CT in primary sclerosing cholangitis. Br J Radiol 1998;71:1279–82.PubMed
29.
Zurück zum Zitat Noji T, Kondo S, Hirano S, Tanaka E, Ambo Y, Kawarada Y, Morikawa T. CT evaluation of paraaortic lymph node metastasis in patients with biliary cancer. J Gastroenterol 2005;40:739–43.CrossRefPubMed Noji T, Kondo S, Hirano S, Tanaka E, Ambo Y, Kawarada Y, Morikawa T. CT evaluation of paraaortic lymph node metastasis in patients with biliary cancer. J Gastroenterol 2005;40:739–43.CrossRefPubMed
30.
Zurück zum Zitat Petrowsky H, Wildbrett P, Husarik DB, Hany TF, Tam S, Jochum W, Clavien PA. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 2006;45:43–50.CrossRefPubMed Petrowsky H, Wildbrett P, Husarik DB, Hany TF, Tam S, Jochum W, Clavien PA. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 2006;45:43–50.CrossRefPubMed
31.
Zurück zum Zitat Lopera JE, Soto JA, Munera F. Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions. Radiology 2001;220:90–6.PubMed Lopera JE, Soto JA, Munera F. Malignant hilar and perihilar biliary obstruction: use of MR cholangiography to define the extent of biliary ductal involvement and plan percutaneous interventions. Radiology 2001;220:90–6.PubMed
32.
Zurück zum Zitat Romagnuolo J, Bardou M, Rahme E, Joseph L, Reinhold C, Barkun AN. Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med 2003;139:547–57.PubMed Romagnuolo J, Bardou M, Rahme E, Joseph L, Reinhold C, Barkun AN. Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med 2003;139:547–57.PubMed
33.
Zurück zum Zitat Barish MA, Yocel EK, Ferrucci JT. Magnetic resonance cholangiopancreatography. New Engl J Med 1999;341:258–64.CrossRefPubMed Barish MA, Yocel EK, Ferrucci JT. Magnetic resonance cholangiopancreatography. New Engl J Med 1999;341:258–64.CrossRefPubMed
34.
Zurück zum Zitat Park MS, Kim TK, Kim KW, Park SW, Lee JK, Kim JS, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology 2004;233:234–40.CrossRefPubMed Park MS, Kim TK, Kim KW, Park SW, Lee JK, Kim JS, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology 2004;233:234–40.CrossRefPubMed
35.
Zurück zum Zitat Figueras J, Llado L, Valls C, Serrano T, Ramos E, Fabregat J, et al. Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Liver Transpl 2000;6:786–94.PubMed Figueras J, Llado L, Valls C, Serrano T, Ramos E, Fabregat J, et al. Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Liver Transpl 2000;6:786–94.PubMed
36.
Zurück zum Zitat Sakamoto E, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M, et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg 1998;227:405–11.CrossRefPubMed Sakamoto E, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M, et al. The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg 1998;227:405–11.CrossRefPubMed
37.
Zurück zum Zitat Hayashi S, Miyazaki M, Kondo Y, Nakajima N. Invasive growth patterns of hepatic hilar ductal carcinoma. A histologic analysis of 18 surgical cases. Cancer 1994;73:2922–9.CrossRefPubMed Hayashi S, Miyazaki M, Kondo Y, Nakajima N. Invasive growth patterns of hepatic hilar ductal carcinoma. A histologic analysis of 18 surgical cases. Cancer 1994;73:2922–9.CrossRefPubMed
38.
Zurück zum Zitat Nimura Y, Kamiya J, Hayakawa N, Shionoya S. Cholangioscopic differentiation of biliary strictures and polyps. Endoscopy 1989;21 Suppl 1:351–6.CrossRefPubMed Nimura Y, Kamiya J, Hayakawa N, Shionoya S. Cholangioscopic differentiation of biliary strictures and polyps. Endoscopy 1989;21 Suppl 1:351–6.CrossRefPubMed
39.
Zurück zum Zitat Nimura Y. Staging of biliary carcinoma: cholangiography and cholangioscopy. Endoscopy 1993;25:76–80.CrossRefPubMed Nimura Y. Staging of biliary carcinoma: cholangiography and cholangioscopy. Endoscopy 1993;25:76–80.CrossRefPubMed
40.
Zurück zum Zitat Itoi T, Sofuni A, Itokawa F, Tsuchiya T, Kurihara T, Ishii K, et al. Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging (with videos). Gastrointest Endosc 2007;66:730–6.CrossRefPubMed Itoi T, Sofuni A, Itokawa F, Tsuchiya T, Kurihara T, Ishii K, et al. Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging (with videos). Gastrointest Endosc 2007;66:730–6.CrossRefPubMed
41.
Zurück zum Zitat Fukuda Y, Tsuyuguchi T, Sakai Y, Tsuchiya S, Saisyo H. Diagnostic utility of peroral cholangioscopy for various bile-duct lesions. Gastrointest Endosc 2005;62:374–82.CrossRefPubMed Fukuda Y, Tsuyuguchi T, Sakai Y, Tsuchiya S, Saisyo H. Diagnostic utility of peroral cholangioscopy for various bile-duct lesions. Gastrointest Endosc 2005;62:374–82.CrossRefPubMed
42.
Zurück zum Zitat Tamada K, Ido K, Ueno N, Ichiyama M, Tomiyama T, Nishizono T, et al. Assessment of hepatic artery invasion by bile duct cancer using intraductal ultrasonography. Endoscopy 1995;27:579–83.CrossRefPubMed Tamada K, Ido K, Ueno N, Ichiyama M, Tomiyama T, Nishizono T, et al. Assessment of hepatic artery invasion by bile duct cancer using intraductal ultrasonography. Endoscopy 1995;27:579–83.CrossRefPubMed
43.
Zurück zum Zitat Tamada K, Nagai H, Yasuda Y, Tomiyama T, Ohashi A, Wada S, et al. Transpapillary intraductal US prior to biliary drainage in the assessment of longitudinal spread of extrahepatic bile duct carcinoma. Gastrointest Endosc 2001;53:300–7.PubMed Tamada K, Nagai H, Yasuda Y, Tomiyama T, Ohashi A, Wada S, et al. Transpapillary intraductal US prior to biliary drainage in the assessment of longitudinal spread of extrahepatic bile duct carcinoma. Gastrointest Endosc 2001;53:300–7.PubMed
44.
Zurück zum Zitat Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P, et al. Positron emission tomography with [(18)F] fluoro-2-deoxy-D glucose for diagnosis and staging of bile duct cancer. Hepatology 2001;33:1029–35.CrossRefPubMed Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P, et al. Positron emission tomography with [(18)F] fluoro-2-deoxy-D glucose for diagnosis and staging of bile duct cancer. Hepatology 2001;33:1029–35.CrossRefPubMed
45.
Zurück zum Zitat Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 2004;8:90–7.CrossRefPubMed Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 2004;8:90–7.CrossRefPubMed
46.
Zurück zum Zitat Cullen SN, Chapman RW. Current management of primary sclerosing cholangitis. Aliment Pharmacol Ther 2005;21:933–48.CrossRefPubMed Cullen SN, Chapman RW. Current management of primary sclerosing cholangitis. Aliment Pharmacol Ther 2005;21:933–48.CrossRefPubMed
47.
Zurück zum Zitat Sugiyama M, Atomi Y, Yamato T. Endoscopic ultrasonography for differential diagnosis of polypoid gallbladder lesions: analysis in surgical and follow up series. Gut 2000;46:250–4.CrossRefPubMed Sugiyama M, Atomi Y, Yamato T. Endoscopic ultrasonography for differential diagnosis of polypoid gallbladder lesions: analysis in surgical and follow up series. Gut 2000;46:250–4.CrossRefPubMed
48.
Zurück zum Zitat Azuma T, Yoshikawa T, Araida T, Takasaki K. Differential diagnosis of polypoid lesion of the gallbladder by endoscopic ultrasonography. Am J Surg 2001;181:65–70.CrossRefPubMed Azuma T, Yoshikawa T, Araida T, Takasaki K. Differential diagnosis of polypoid lesion of the gallbladder by endoscopic ultrasonography. Am J Surg 2001;181:65–70.CrossRefPubMed
49.
Zurück zum Zitat Hirooka Y, Naitoh Y, Goto H, Ito A, Hayakawa S, Watanabe Y, et al. Contrast-enhanced endoscopic ultrasonography in gallbladder diseases. Gastrointest Endosc 1998;48:406–10.CrossRefPubMed Hirooka Y, Naitoh Y, Goto H, Ito A, Hayakawa S, Watanabe Y, et al. Contrast-enhanced endoscopic ultrasonography in gallbladder diseases. Gastrointest Endosc 1998;48:406–10.CrossRefPubMed
50.
Zurück zum Zitat Sadamoto Y, Kubo H, Harada N, Tanaka M, Eguchi T, Hawata H. Preoperative diagnosis and staging of gallbladder carcinoma by EUS. Gastrointest Endosc 2003;58:536–41.CrossRefPubMed Sadamoto Y, Kubo H, Harada N, Tanaka M, Eguchi T, Hawata H. Preoperative diagnosis and staging of gallbladder carcinoma by EUS. Gastrointest Endosc 2003;58:536–41.CrossRefPubMed
51.
Zurück zum Zitat Furukawa H, Kosuge T, Shimada K, Yamamoto J, Kanai Y, Mukai K, et al. Small polypoid lesions of the gallbladder. Arch Surg 1998;133:735–9.CrossRefPubMed Furukawa H, Kosuge T, Shimada K, Yamamoto J, Kanai Y, Mukai K, et al. Small polypoid lesions of the gallbladder. Arch Surg 1998;133:735–9.CrossRefPubMed
52.
Zurück zum Zitat Yoshimitsu K, Honda H, Shinozaki K, Aibe H, Kuroiwa T, Irie H, et al. Helical CT of the local spread of carcinoma of the gallbladder: evaluation according to the TNM system in patients who underwent surgical resection. AJR Am J Roentgenol 2002; 179:423–8.PubMed Yoshimitsu K, Honda H, Shinozaki K, Aibe H, Kuroiwa T, Irie H, et al. Helical CT of the local spread of carcinoma of the gallbladder: evaluation according to the TNM system in patients who underwent surgical resection. AJR Am J Roentgenol 2002; 179:423–8.PubMed
53.
Zurück zum Zitat Ohtani T, Shirai Y, Tsukada K, Muto T, Hatakeyama K. Spread of gallbladder carcinoma: CT evaluation with pathologic correlation. Abdom Imaging 1996;21:195–201.CrossRefPubMed Ohtani T, Shirai Y, Tsukada K, Muto T, Hatakeyama K. Spread of gallbladder carcinoma: CT evaluation with pathologic correlation. Abdom Imaging 1996;21:195–201.CrossRefPubMed
54.
Zurück zum Zitat Engels JT, Balfe DM, Lee JKT. Biliary carcinoma: CT evaluation of extrahepatic spread. Radiology 1989;172:35–40.PubMed Engels JT, Balfe DM, Lee JKT. Biliary carcinoma: CT evaluation of extrahepatic spread. Radiology 1989;172:35–40.PubMed
55.
Zurück zum Zitat Ohtani T, Shirai Y, Tsukada K. Carcinoma of the gallbladder: CT evaluation of lymphatic spread. Radiology 1993;189:875–80.PubMed Ohtani T, Shirai Y, Tsukada K. Carcinoma of the gallbladder: CT evaluation of lymphatic spread. Radiology 1993;189:875–80.PubMed
56.
Zurück zum Zitat Kumaran V, Gulati S, Paul B, Pande GK, Sahni P, Chattopadhyay TK. The role of dual-phase helical CT in assessing resectability of carcinoma of the gallbladder. Eur Radiol 2002;12:1993–9.PubMed Kumaran V, Gulati S, Paul B, Pande GK, Sahni P, Chattopadhyay TK. The role of dual-phase helical CT in assessing resectability of carcinoma of the gallbladder. Eur Radiol 2002;12:1993–9.PubMed
57.
Zurück zum Zitat Kaneoka Y, Yamaguchi A, Isogai M, Harada T, Suzuki M. Hepatoduodenal ligament invasion by gallbladder carcinoma: histologic pattern and surgical recommendation. World J Surg 2003;27:260–5.CrossRefPubMed Kaneoka Y, Yamaguchi A, Isogai M, Harada T, Suzuki M. Hepatoduodenal ligament invasion by gallbladder carcinoma: histologic pattern and surgical recommendation. World J Surg 2003;27:260–5.CrossRefPubMed
58.
Zurück zum Zitat Nakata T, Kobayashi A, Miwa S, Soeda J, Miyagawa S. Impact of tumor spread to the cystic duct on the prognosis of patients with gallbladder carcinoma World J Surg 2007;31:155–61.CrossRefPubMed Nakata T, Kobayashi A, Miwa S, Soeda J, Miyagawa S. Impact of tumor spread to the cystic duct on the prognosis of patients with gallbladder carcinoma World J Surg 2007;31:155–61.CrossRefPubMed
59.
Zurück zum Zitat Rajagopalan V, Daines WP, Grossbard ML, Kozuch P. Gallbladder and biliary tract carcinoma: a comprehesive update, part 1. Oncology 2004;18:889–96.PubMed Rajagopalan V, Daines WP, Grossbard ML, Kozuch P. Gallbladder and biliary tract carcinoma: a comprehesive update, part 1. Oncology 2004;18:889–96.PubMed
60.
Zurück zum Zitat Verma K, Bhargava DK. Cytologic examination as an adjunct to laparoscopy and guided biopsy in the diagnosis of hepatic and gallbladder neoplasia. Acta Cytol 1982;26:311–6.PubMed Verma K, Bhargava DK. Cytologic examination as an adjunct to laparoscopy and guided biopsy in the diagnosis of hepatic and gallbladder neoplasia. Acta Cytol 1982;26:311–6.PubMed
61.
Zurück zum Zitat Ishikawa O, Ohhigashi H, Sasaki Y, Imaoka T, Wada A, Ishiguro S, et al. The usefulness of saline irrigated bile for the intraoperative cytologic diagnosis of tumors and tumorlike lesions of the gallbladder. Acta Cytol 1988;32:475–81.PubMed Ishikawa O, Ohhigashi H, Sasaki Y, Imaoka T, Wada A, Ishiguro S, et al. The usefulness of saline irrigated bile for the intraoperative cytologic diagnosis of tumors and tumorlike lesions of the gallbladder. Acta Cytol 1988;32:475–81.PubMed
62.
Zurück zum Zitat Akosa AB, Barker F, Desa L, Benjamin I, Krausz T. Cytologic diagnosis in the management of gallbladder carcinoma. Acta Cytol 1995;39:494–8.PubMed Akosa AB, Barker F, Desa L, Benjamin I, Krausz T. Cytologic diagnosis in the management of gallbladder carcinoma. Acta Cytol 1995;39:494–8.PubMed
63.
Zurück zum Zitat Kim JH, Kim TK, Eun HW. Preoperative evaluation of gallbladder carcinoma: efficacy of combined use of MR imaging, MR cholangigraphy, and contrast-enhanced dual phase three dimensional MR angiography. J Magn Reson Imaging 2002;16:676–84.CrossRefPubMed Kim JH, Kim TK, Eun HW. Preoperative evaluation of gallbladder carcinoma: efficacy of combined use of MR imaging, MR cholangigraphy, and contrast-enhanced dual phase three dimensional MR angiography. J Magn Reson Imaging 2002;16:676–84.CrossRefPubMed
64.
Zurück zum Zitat Schwartz LH, Black J, Fong, Jarnagin W, Blumgart L, Gruen D, et al. Gallbladder carcinoma: findings at MR imaging with MR cholangiopancreatography 2002;26:405–10. Schwartz LH, Black J, Fong, Jarnagin W, Blumgart L, Gruen D, et al. Gallbladder carcinoma: findings at MR imaging with MR cholangiopancreatography 2002;26:405–10.
65.
Zurück zum Zitat Futakawa N, Kimura W, Wada Y, Muto T. Clinicopathological characteristics and surgical procedures for carcinoma of the papilla of Vater. Hepatogastroenterology 1996;43:260–7.PubMed Futakawa N, Kimura W, Wada Y, Muto T. Clinicopathological characteristics and surgical procedures for carcinoma of the papilla of Vater. Hepatogastroenterology 1996;43:260–7.PubMed
66.
Zurück zum Zitat Mortele JK, Ji H, Ros PR. CT and magnetic resonance imaging in pancreatic and biliary tract malignancies. Gastrointest Endosc 2002;56:206–12.CrossRef Mortele JK, Ji H, Ros PR. CT and magnetic resonance imaging in pancreatic and biliary tract malignancies. Gastrointest Endosc 2002;56:206–12.CrossRef
67.
Zurück zum Zitat Yamaguchi K, Enjoji M, Kitamura K. Endoscopic biopsy has limited accuracy in diagnosis of ampullary tumors. Gastrointest Endosc 1990;36:588–92.CrossRefPubMed Yamaguchi K, Enjoji M, Kitamura K. Endoscopic biopsy has limited accuracy in diagnosis of ampullary tumors. Gastrointest Endosc 1990;36:588–92.CrossRefPubMed
68.
Zurück zum Zitat Bohnacker S, Soehendra N, Maguchi H, Chung JB, Howell DA. Endoscopic resection of benign tumors of the papilla of Vater. Endoscopy 2006;38:521–5.CrossRefPubMed Bohnacker S, Soehendra N, Maguchi H, Chung JB, Howell DA. Endoscopic resection of benign tumors of the papilla of Vater. Endoscopy 2006;38:521–5.CrossRefPubMed
69.
Zurück zum Zitat Menzel J, Hoepffner N, Sulkowski U, Reimer P, Heinecke A, Poremba C, Domschke W. Polypoid tumors of the major duodenal papilla: preoperative staging with intraductal US, EUS, and CT-a prospective, histopathologically controlled study. Gastrointest Endosc 1999;49:349–57.CrossRefPubMed Menzel J, Hoepffner N, Sulkowski U, Reimer P, Heinecke A, Poremba C, Domschke W. Polypoid tumors of the major duodenal papilla: preoperative staging with intraductal US, EUS, and CT-a prospective, histopathologically controlled study. Gastrointest Endosc 1999;49:349–57.CrossRefPubMed
70.
Zurück zum Zitat Itoh A, Goto H, Naitoh Y, Hirooka Y, Furukawa T, Hayakawa T. Intraductal ultrasonography in diagnosing tumor extension of cancer of the papilla of Vater. Gastrointest Endosc 1997;45:251–60.CrossRefPubMed Itoh A, Goto H, Naitoh Y, Hirooka Y, Furukawa T, Hayakawa T. Intraductal ultrasonography in diagnosing tumor extension of cancer of the papilla of Vater. Gastrointest Endosc 1997;45:251–60.CrossRefPubMed
Metadaten
Titel
Diagnosis of biliary tract and ampullary carcinomas
verfasst von
Kazuhiro Tsukada
Tadahiro Takada
Masaru Miyazaki
Shuichi Miyakawa
Masato Nagino
Satoshi Kondo
Junji Furuse
Hiroya Saito
Toshio Tsuyuguchi
Fumio Kimura
Hideyuki Yoshitomi
Satoshi Nozawa
Masahiro Yoshida
Keita Wada
Hodaka Amano
Fumihiko Miura
Publikationsdatum
01.01.2008
Verlag
Springer-Verlag
Erschienen in
Journal of Hepato-Biliary-Pancreatic Sciences / Ausgabe 1/2008
Print ISSN: 1868-6974
Elektronische ISSN: 1868-6982
DOI
https://doi.org/10.1007/s00534-007-1278-6

Weitere Artikel der Ausgabe 1/2008

Journal of Hepato-Biliary-Pancreatic Sciences 1/2008 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.